Orthofix Gains FDA and CE Mark Approvals for PhysioStim

Orthofix gained FDA premarket approval and approval under the CE Mark in the EU for next-gen PhysioStim™ bone growth stimulators, used as a nonsurgical treatment for nonunion fracture in the extremities.

The Class III device emits a pulsed electromagnetic field signal at the fracture site to stimulate bone healing, and is complemented by...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us